Nasdaq

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
Business Wire

Genvira and Labskin Receive £1.2 Million ($2.0 Million) UK–Canada Collaboration Award to Advance Immunotherapies for Malignant Melanoma

OTTAWA, Ontario & YORK, England--(BUSINESS WIRE)--Genvira Biosciences Inc. (“Genvira”), a Canadian innovator in next-generation viral vectors, Labskin Limited (“Labskin”), a leader in 3D in vitro ...
MarketWatch

Viral Vector Vaccines Strategic Business Research Report 2024-2030 | Expanding Pipeline of Infectious Disease Targets Strengthens the Commercial Outlook - ResearchAndMarkets.com

The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
MarketWatch

Adeno-Associated Viral (AAV) Vector Market Research, Industry Trends and Global Forecasts, 2035 by Type of Therapy, Therapeutic Area, Route of Administration, Scale of ...

The "Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and ...
The American Journal of Managed Care

The State and Future of Viral, Nonviral Vectors for Gene Therapy

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...